Ricardo Nalda-Molina

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Systematic Review

Ulcerative Colitis

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Iván Beltrá-Picó, Marcos Díaz-González, Ricardo Nalda-Molina, Amelia Ramon-Lopez, Sonia Pascual-Bartolomé, Cayetano F Miralles-Maciá, María Rodríguez-Soler, Patricio Más-Serrano
Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report. British journal of clinical pharmacology 90 (7) (2024)
Iván Beltrá-Picó, Marcos Díaz-González, Ricardo Nalda-Molina, Amelia Ramon-Lopez, Sonia Pascual-Bartolomé, Cayetano F Miralles-Maciá, María Rodríguez-Soler, Patricio Más-Serrano
Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report. British journal of clinical pharmacology (2024)
Silvia Marquez-Megias, Ricardo Nalda-Molina, Patricio Más-Serrano, Amelia Ramon-Lopez
Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data. Biomedicines 11 (10) (2023)
Silvia Marquez-Megias, Ricardo Nalda-Molina, Javier Sanz-Valero, Patricio Más-Serrano, Marcos Diaz-Gonzalez, Maria Remedios Candela-Boix, Amelia Ramon-Lopez
Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review. Pharmaceutics 14 (5) (2022)
Efthymios Neroutsos, Ricardo Nalda-Molina, Anna Paisiou, Kalliopi Zisaki, Evgenios Goussetis, Alexandros Spyridonidis, Vasiliki Kitra, Stelios Grafakos, Georgia Valsami, Aristides Dokoumetzidis
Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing. Pharmaceutics 14 (3) (2022)